FDA

News and Updates by the Food and Drugs Administration (FDA)

Ariceum and Eckert & Ziegler Forge International Partnership for Advanced Radiotherapeutics in Precision Cancer Care

**Ariceum Therapeutics** (Ariceum), a private biotech company specializing in radiopharmaceutical development for diagnosing and treating challenging cancer types, alongside **Eckert & Ziegler**, a leading global distributor of medical isotopes for various applications, have officially entered into a worldwide supply pact

Ariceum and Eckert & Ziegler Forge International Partnership for Advanced Radiotherapeutics in Precision Cancer Care Read More »

KISMA Requests NCISM to Eliminate Two Regulations Impacting Ayurveda Institutions

Expressing apprehensions about the recent guidelines issued by the National Commission for Indian System of Medicines (NCISM), which pertain to hiring new faculty and acquiring contemporary equipment in existing Ayurveda colleges, the Kerala ISM College Management Association (KISMA) has advocated

KISMA Requests NCISM to Eliminate Two Regulations Impacting Ayurveda Institutions Read More »

Call for Stronger Regulation to Combat AMR as Antibiotics Face Critical Threat: Dr. Neetu Mittal

Dr. Neetu Mittal, a senior consultant specializing in infection control and microbiology at Sarvodaya Hospital in Faridabad, has issued a warning regarding the growing threat of antimicrobial resistance (AMR). She identifies significant problems in antibiotic regulation and the failure to

Call for Stronger Regulation to Combat AMR as Antibiotics Face Critical Threat: Dr. Neetu Mittal Read More »

Essential Role of OPD Insurance in Preventative Healthcare and Early Diagnosis: Specialist Insights

**Content:** OPD (out-patient department) insurance plays a crucial role in preventive healthcare and early diagnosis. This type of insurance effectively fills a significant gap by covering day-to-day medical expenses, consultations, diagnostic tests, and minor procedures. It’s a vital resource for

Essential Role of OPD Insurance in Preventative Healthcare and Early Diagnosis: Specialist Insights Read More »

Datopotamab Deruxtecan Shows Promising Results in Pre-Treated Advanced EGFR-Mutated NSCLC in Joint TROPION-Lung05 & TROPION-Lung01 Study

### Datopotamab Deruxtecan Impresses in Combination Study of Patients with Previously Treated Advanced or Metastatic EGFR-Mutated NSCLC An analysis combining data from the TROPION-Lung05 phase 2 and TROPION-Lung01 phase 3 studies has shown that datopotamab deruxtecan (Dato-DXd) leads to notable

Datopotamab Deruxtecan Shows Promising Results in Pre-Treated Advanced EGFR-Mutated NSCLC in Joint TROPION-Lung05 & TROPION-Lung01 Study Read More »

Lungpacer Medical Secures FDA Approval for AeroPace Neurostimulation System

Lungpacer Medical announced it has obtained premarket approval from the FDA for their leading AeroPace neurostimulation device. The AeroPace system utilizes neurostimulation through an electrode-equipped cardiovascular catheter and a software-driven management system. It periodically stimulates the phrenic nerve via the

Lungpacer Medical Secures FDA Approval for AeroPace Neurostimulation System Read More »